192 related articles for article (PubMed ID: 31141643)
1. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.
de Vos M; Ley SD; Wiggins KB; Derendinger B; Dippenaar A; Grobbelaar M; Reuter A; Dolby T; Burns S; Schito M; Engelthaler DM; Metcalfe J; Theron G; van Rie A; Posey J; Warren R; Cox H
N Engl J Med; 2019 May; 380(22):2178-2180. PubMed ID: 31141643
[No Abstract] [Full Text] [Related]
2. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.
Bloemberg GV; Keller PM; Stucki D; Trauner A; Borrell S; Latshang T; Coscolla M; Rothe T; Hömke R; Ritter C; Feldmann J; Schulthess B; Gagneux S; Böttger EC
N Engl J Med; 2015 Nov; 373(20):1986-8. PubMed ID: 26559594
[TBL] [Abstract][Full Text] [Related]
3. Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis.
Mohr E; Ferlazzo G; Hewison C; De Azevedo V; Isaakidis P
Lancet Infect Dis; 2019 May; 19(5):470. PubMed ID: 31034392
[No Abstract] [Full Text] [Related]
4. Rapid emergence of
Veziris N; Bernard C; Guglielmetti L; Le Du D; Marigot-Outtandy D; Jaspard M; Caumes E; Lerat I; Rioux C; Yazdanpanah Y; Tiotiu A; Lemaitre N; Brossier F; Jarlier V; Robert J; Sougakoff W; Aubry A; ;
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182568
[No Abstract] [Full Text] [Related]
5. Multidrug-resistant tuberculosis and bedaquiline.
Salfinger M; Somoskövi A
N Engl J Med; 2014 Dec; 371(25):2435-6. PubMed ID: 25517715
[No Abstract] [Full Text] [Related]
6. Multidrug-resistant tuberculosis and bedaquiline.
Diacon AH; Lounis N; Dannemann B
N Engl J Med; 2014 Dec; 371(25):2436. PubMed ID: 25517714
[No Abstract] [Full Text] [Related]
7. FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.
Cox E; Laessig K
N Engl J Med; 2014 Aug; 371(8):689-91. PubMed ID: 25140952
[No Abstract] [Full Text] [Related]
8. Current issues with the use of bedaquiline.
Kakkar AK; Dahiya N
Ann Pharmacother; 2014 May; 48(5):666. PubMed ID: 24519480
[No Abstract] [Full Text] [Related]
9. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.
Andres S; Merker M; Heyckendorf J; Kalsdorf B; Rumetshofer R; Indra A; Hofmann-Thiel S; Hoffmann H; Lange C; Niemann S; Maurer FP
Am J Respir Crit Care Med; 2020 Jun; 201(12):1564-1568. PubMed ID: 32053752
[No Abstract] [Full Text] [Related]
10. Bedaquiline or delamanid for rifampin-resistant tuberculosis?
Lessem E; Cox V; Furin J
Lancet Respir Med; 2017 Oct; 5(10):772-774. PubMed ID: 28887015
[No Abstract] [Full Text] [Related]
11. Bedaquiline.
Goulooze SC; Cohen AF; Rissmann R
Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
[No Abstract] [Full Text] [Related]
12. Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India.
Udwadia ZF; Amale RA; Mullerpattan JB
Int J Tuberc Lung Dis; 2014 Nov; 18(11):1315-8. PubMed ID: 25299863
[TBL] [Abstract][Full Text] [Related]
13. Bedaquiline for the treatment of drug-resistant tuberculosis.
Bélard S; Heuvelings CC; Janssen S; Grobusch MP
Expert Rev Anti Infect Ther; 2015 May; 13(5):535-53. PubMed ID: 25797824
[TBL] [Abstract][Full Text] [Related]
14. BPaL approved for multidrug-resistant tuberculosis.
Burki T
Lancet Infect Dis; 2019 Oct; 19(10):1063-1064. PubMed ID: 31559963
[No Abstract] [Full Text] [Related]
15. Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
Bouton TC; de Vos M; Ragan EJ; White LF; Van Zyl L; Theron D; Horsburgh CR; Warren RM; Jacobson KR
PLoS One; 2019; 14(10):e0223308. PubMed ID: 31622366
[TBL] [Abstract][Full Text] [Related]
16. Multidrug Resistant Tuberculosis With Simultaneously Acquired Drug Resistance to Bedaquiline and Delamanid.
Yoshiyama T; Takaki A; Aono A; Mitarai S; Okumura M; Ohta K; Kato S
Clin Infect Dis; 2021 Dec; 73(12):2329-2331. PubMed ID: 32730621
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
Diacon AH; Pym A; Grobusch MP; de los Rios JM; Gotuzzo E; Vasilyeva I; Leimane V; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; De Paepe E; van Heeswijk RP; Dannemann B;
N Engl J Med; 2014 Aug; 371(8):723-32. PubMed ID: 25140958
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment.
Lange C; Chesov D; Heyckendorf J; Leung CC; Udwadia Z; Dheda K
Respirology; 2018 Jul; 23(7):656-673. PubMed ID: 29641838
[TBL] [Abstract][Full Text] [Related]
19. Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
Achar J; Hewison C; Cavalheiro AP; Skrahina A; Cajazeiro J; Nargiza P; Herboczek K; Rajabov AS; Hughes J; Ferlazzo G; Seddon JA; du Cros P
Emerg Infect Dis; 2017 Oct; 23(10):1711-3. PubMed ID: 28758889
[TBL] [Abstract][Full Text] [Related]
20. Bedaquiline (Sirturo) for multidrug-resistant tuberculosis.
Med Lett Drugs Ther; 2013 Aug; 55(1423):66-8. PubMed ID: 23959388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
